Bill
LD 582
Overview: LD 582, "An Act To Require Health Insurance Carriers To Provide Coverage For Blood Testing For Perfluoroalkyl And Polyfluoroalkyl Substances", was carried over to the nex
Overview: LD 582, "An Act To Require Health Insurance Carriers To Provide Coverage For Blood Testing For Perfluoroalkyl And Polyfluoroalkyl Substances", was carried over to the next legislative session pursuant to a joint order.
Purpose and Intent: The purpose of this bill is to require health insurance carriers in the state to provide coverage for blood testing related to perfluoroalkyl and polyfluoroalkyl substances (PFAS). The intent is to ensure that individuals can access and afford this type of medical testing.
Key Provisions:
- Mandates that all health insurance plans cover PFAS blood testing for their enrollees
- Prohibits insurance carriers from imposing deductibles, copayments, or other cost-sharing for PFAS blood tests
- Requires the state insurance department to enforce the coverage mandate and monitor compliance
Affected Parties and Impacts: The primary affected parties would be individuals who may need PFAS blood testing, as well as the health insurance carriers operating in the state. The bill aims to improve access to this type of medical testing by eliminating financial barriers.
Procedural and Timeline Considerations: This bill was carried over to the next legislative session, meaning it will be considered again in the 132nd Legislature. No further action will be taken on the current version of the bill until the next session convenes.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
